Skip to search.
 TSX Up 0.60% TSX Ventures Up 1.02%

Dyax Corp. (DYAX)

-NasdaqGM
24.61 Up 0.58(2.41%) 4:00PM EDT
|After Hours : 24.61 0.00 (0.00%) 4:43PM EDT
Add to Portfolio
Prev Close:24.03
Open:24.20
Bid:22.56 x 300
Ask:24.88 x 100
1y Target Est:29.63
Beta:0.78
Earnings Date:Oct 26 - Oct 30 (Est.)
Day's Range:23.05 - 25.12
52wk Range:8.83 - 30.55
Volume:840,592
Avg Vol (3m):1,000,530
Market Cap:3.59B
P/E (ttm):N/A
EPS (ttm):-0.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DYAXUp 2.41%3.59B
SHPGUp 1.63%52.52B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):39.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.28
Quarterly EPS Est (Sep-15) :-0.08
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-2.80

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback